Northwest Biotherapeutics Inc (NWBO.OQ)

NWBO.OQ on NASDAQ Stock Exchange Capital Market

5.61USD
12:54pm EST
Price Change (% chg)

$-0.08 (-1.41%)
Prev Close
$5.69
Open
$5.67
Day's High
$5.67
Day's Low
$5.51
Volume
91,309
Avg. Vol
132,537
52-wk High
$10.60
52-wk Low
$3.21

NWBO.OQ

Chart for NWBO.OQ

About

Northwest Biotherapeutics, Inc. is a development-stage company. The Company focuses on discovering, developing, and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company's approach in developing cancer therapies utilizes its capability in the biology of dendritic... (more)

Overall

Beta: 2.91
Market Cap (Mil.): $354.02
Shares Outstanding (Mil.): 62.22
Dividend: --
Yield (%): --

Financials

  NWBO.OQ Industry Sector
P/E (TTM): -- 180.08 38.03
EPS (TTM): -2.10 -- --
ROI: -- -0.62 18.26
ROE: -- -1.77 19.16
Search Stocks

UPDATE 1-Northwest Bio drug for inoperable tumors safe so far -researcher

June 19 - An experimental Northwest Biotherapeutics Inc drug for inoperable tumors has shown no signs of toxicity in an ongoing safety trial being conducted at M.D. Anderson Cancer Center, the trial's researcher said on Thursday.

19 Jun 2014

CORRECTED-Northwest Bio drug for inoperable tumors safe so far -researcher

June 19 - An experimental Northwest Biotherapeutics Inc drug for inoperable tumors has shown no signs of toxicity in an ongoing safety trial being conducted at M.D. Anderson Cancer Center, the trial's researcher said on Thursday.

19 Jun 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Factual Report
$150.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks